Laboratory Corporation of America Holdings
NYSE:LH
Laboratory Corporation of America Holdings
Accounts Receivables
Laboratory Corporation of America Holdings
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Laboratory Corporation of America Holdings
NYSE:LH
|
Accounts Receivables
$2.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
|
DaVita Inc
NYSE:DVA
|
Accounts Receivables
$2.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
Chemed Corp
NYSE:CHE
|
Accounts Receivables
$177.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Accounts Receivables
$1.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Accounts Receivables
$10.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
2%
|
|
Cigna Corp
NYSE:CI
|
Accounts Receivables
$20.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Laboratory Corporation of America Holdings's Accounts Receivables?
Accounts Receivables
2.2B
USD
Based on the financial report for Mar 31, 2024, Laboratory Corporation of America Holdings's Accounts Receivables amounts to 2.2B USD.
What is Laboratory Corporation of America Holdings's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
10%
Over the last year, the Accounts Receivables growth was -28%. The average annual Accounts Receivables growth rates for Laboratory Corporation of America Holdings have been -9% over the past three years , 2% over the past five years , and 10% over the past ten years .